Doctor Evidence Conflicts of Interest Policy

Doctor Evidence (DRE) is a leader in technological solutions for Evidence-Based Medicine (EBM) with a mission to support efforts of healthcare providers and patients to gain access to important knowledge, based on the most timely and relevant medical evidence and related analytics, to inform clinical decisions and improve the health and wellbeing of patients worldwide. This specialty software and services company’s methodology uses a Digital Outcome Conversion (DOC™) approach for transforming data from published clinical studies, epidemiological databases, and other sources, into reusable and updatable databases to facilitate methodologically rigorous analyses.  The scope and content of any particular data in the platform is the subject of the client organization using the platform (such as a Microsoft Word or Excel document), and DRE is completely agnostic to how much, or how little, content is used in the platform.

Thus, the data must be accurate, reliable, and trusted by all users. There is no room for error and no room for biases. Doctor Evidence has spent 12 years perfecting the processes and technologies so that they support the science and meet or exceed all of the standards of evidence-based medicine (EBM), including the Institute of Medicine, Guidelines International Network, and Council of Medical Specialty Societies. DRE is proud to provide high quality evidence-based information to support the work of its clients.

Although Doctor Evidence is a commercial company with clients across the spectrum of healthcare, the EBM methods it employs, the technological solutions it has developed, and the policies it has established are designed to produce the best available evidence and dependable analytics to inform patient care decisions and improve patient outcomes. All stakeholders can benefit from these EBM techniques and no stakeholders are excluded from using the DRE platforms so that all are encouraged to use evidence to support healthcare decisions and solutions.

The digitized data from the published clinical trials and other studies is the intellectual property (IP) of Doctor Evidence. The results of the analyses we conduct for, or with our clients or that they perform in our platforms are the IP of the clients. Any recommendations, formularies, regulatory submissions, or other documents that are produced by DRE clients, based on evidence or analyses resulting from use of the Doctor Evidence platforms or technologies, are the IP of that client and do not represent DRE or the opinions of DRE.

The transparency of the data and the methods will ensure replication of projects and permit investigations in the event of any concerns. DRE will be entitled to reimbursement for costs associated with any such project replications.

As a privately held company, DRE is not required to disclose the names of its clients.